Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.730

+10.2%

3:57 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: panteon who wrote (5834)	1/2/2000 11:19:00 AM
From: DanZ	Read Replies (2) of 10293

The folks who compare Quigley to Gum Tech obviously haven't done much research. Perhaps you need to go back to the drawing board and figure out what nicotine gum and dental gum are, and estimate Gum Tech's future cash flows from just these two products. Even if you are right about Zicam, which I completely disagree with, Gum Tech is undervalued based on projections for nicotine gum and dental gum. Comparing Quigley to Gum Tech shows a gross ignorance of the total business of these two companies. You opine that GUMM may be a slow decliner. I opine that GUMM might rally to a minimum of 25 to 30 when the independent clinical studies are released that prove Zicam has therapeutic and prophylactic benefits against the common cold. Why do I think that the studies will return positive results? Because of many personal experiences and the experiences of people all around the country that I trust. There is also plenty of circumstancial evidence related to why Gum Tech hasn't released the results yet (which were due in October). Do you think that they might have submitted the study results for publication and are awaiting publication before they release the results? Regards, Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next